S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Bank Accounts: Frozen! (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Bank Accounts: Frozen! (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Bank Accounts: Frozen! (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Bank Accounts: Frozen! (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Bank Accounts: Frozen! (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Bank Accounts: Frozen! (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Bank Accounts: Frozen! (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Bank Accounts: Frozen! (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament

Tabula Rasa HealthCare - TRHC Stock Forecast, Price & News

$5.00
-0.16 (-3.10%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.83
$5.15
50-Day Range
$4.91
$6.51
52-Week Range
$2.09
$6.69
Volume
525,115 shs
Average Volume
87,271 shs
Market Capitalization
$134.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

Tabula Rasa HealthCare MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
10.0% Upside
$5.50 Price Target
Short Interest
Bearish
7.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.93) to ($0.67) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.13 out of 5 stars

Medical Sector

986th out of 1,005 stocks

Business Services, Not Elsewhere Classified Industry

91st out of 92 stocks


TRHC stock logo

About Tabula Rasa HealthCare (NASDAQ:TRHC) Stock

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

TRHC Stock News Headlines

Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Q4 2022 Tabula Rasa HealthCare Inc Earnings Call
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Tabula Rasa HealthCare Is Dead Money
Tabula Rasa HealthCare Reports Third Quarter 2022 Results
See More Headlines
Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

TRHC Company Calendar

Last Earnings
11/04/2021
Today
3/26/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRHC
Fax
N/A
Employees
1,027
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.50
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+10.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-147,510,000.00
Pretax Margin
-25.69%

Debt

Sales & Book Value

Annual Sales
$299.52 million
Book Value
($2.10) per share

Miscellaneous

Free Float
24,923,000
Market Cap
$134.35 million
Optionable
Optionable
Beta
1.54

Key Executives

  • Brian W. AdamsBrian W. Adams
    President & Chief Executive Officer
  • Michael GreenhalghMichael Greenhalgh
    Chief Operating Officer
  • Thomas J. Cancro
    Chief Financial & Accounting Officer
  • Joseph J. Filippoli
    Chief Information Officer
  • Jacques Turgeon
    Chief Scientific Officer













TRHC Stock - Frequently Asked Questions

Should I buy or sell Tabula Rasa HealthCare stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TRHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View TRHC analyst ratings
or view top-rated stocks.

What is Tabula Rasa HealthCare's stock price forecast for 2023?

3 Wall Street analysts have issued 12 month price targets for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $5.00 to $6.00. On average, they predict the company's stock price to reach $5.50 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts price targets for TRHC
or view top-rated stocks among Wall Street analysts.

How have TRHC shares performed in 2023?

Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of 2023. Since then, TRHC shares have increased by 1.0% and is now trading at $5.00.
View the best growth stocks for 2023 here
.

When is Tabula Rasa HealthCare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our TRHC earnings forecast
.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings data on Thursday, November, 4th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.19) by $0.15. The firm had revenue of $86.60 million for the quarter, compared to analysts' expectations of $88.54 million. Tabula Rasa HealthCare had a negative net margin of 49.25% and a negative trailing twelve-month return on equity of 472.90%. The business's revenue for the quarter was up 22.8% compared to the same quarter last year. During the same period last year, the company posted ($0.35) EPS.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its first quarter 2023 earnings guidance on Monday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $82.00 million-$84.00 million, compared to the consensus revenue estimate of $76.27 million.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different institutional and retail investors. Top institutional investors include UBS Group AG (4.80%), Fuller & Thaler Asset Management Inc. (1.30%), Millennium Management LLC (1.19%), Spears Abacus Advisors LLC (0.90%), Geode Capital Management LLC (0.87%) and Bank of Montreal Can (0.81%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro.
View institutional ownership trends
.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $5.00.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $134.35 million and generates $299.52 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($6.09) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

The company employs 1,027 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com.

This page (NASDAQ:TRHC) was last updated on 3/26/2023 by MarketBeat.com Staff